In particular, TRIM31 up-regulates the levels of nuclear p65 by promoting K63-linked polyubiquitination of tumour necrosis factor receptor-associated factor 2 (TRAF2) and sustains the activation of NF-κB in pancreatic cancer cells. Here, TRIM31 is linked to familial pancreatic carcinoma.